Belimumab
- IVBelimumabBenlysta
- Mechanism of Action
- A human monoclonal antibody to B lymphocyte stimulator (BLyS, also known as BAFF), a member of the TNF family that inhibits B cell apoptosis and stimulates differentiation of B cells.
Clinical Use
- Indication
- Antibody-positive systemic lupus erythematosus (SLE).
- Adverse Effects